AKT1 and Alzheimer disease: In addition to reducing Aβ plaques, ultrasonic treatment can also increase the occurrence of hippocampal neurons in AD mouse models, and induce the phospholipids inositol 3 kinase-protein kinase-rapamycin target protein (PI3K-Akt–mTOR) signaling pathway.